Details for Patent: 12,295,932

Which drugs does patent 12,295,932 protect, and when does it expire?

Patent 12,295,932 protects SUCCINYLCHOLINE CHLORIDE and is included in one NDA.

Summary for Patent: 12,295,932

Title:	Succinylcholine chloride prefilled syringe
Abstract:	Prefilled syringes containing a succinylcholine chloride composition, where the prefilled syringes comprise a syringe barrel and a syringe tip comprising cyclic olefin monopolymer (“COP”) or cyclic olefin copolymer (“COC”). The syringes can also comprise a luer adapter integral with the syringe tip, where the syringe barrel, syringe tip and luer adapter are a single element comprising COP or COC. The succinylcholine chloride compositions include succinylcholine chloride, a tonicity agent and one or more pH adjusters in an aqueous solution having a pH from about 3.0-4.5. The prefilled syringes containing the succinylcholine compositions are storage-stable for extended periods of time at a temperature of 2-8° C., have acceptable physical parameters such as glide force and break force, and make safe and robust connections with needles and needleless luer adapter devices (“NLADs”).
Inventor(s):	Keith Jarmusik, Ragheb M. AbuRmaileh
Assignee:	Hikma Pharmaceuticals USA Inc
Application Number:	US17/517,808
Patent Claim Types: see list of patent claims	Composition; Device;

Drugs Protected by US Patent 12,295,932

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Hikma	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	SOLUTION;INTRAMUSCULAR, INTRAVENOUS	215143-001	Aug 20, 2021		DISCN	Yes	No	12,295,932		Y